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Background: Since 2009, when the revised Pharmaceutical Affairs Act was enacted in Japan, self-medication
practices have increased. Because the concept of self-medication was recently introduced in Japan, few studies
exist on this topic. Therefore, it is necessary to explore how self-medication is practiced. This study examined
Japanese consumers’ self-medication practices and attitudes toward over-the-counter (OTC) medicines based on
their sex, age, and socioeconomic status (SES).
Methods: The participants were 403 adults (Mage = 41.1 years, SD = 16.22). A quota sampling method was
employed based on age group, and participants completed an online questionnaire.
Results: Participants in the 20–29 age group reported medical costs as an obstacle in seeing a doctor; in contrast,
transportation was a mitigating factor for elderly people. Regarding SES, people at lower SES levels chose to rest
instead of seeing a doctor or purchasing over-the-counter (OTC) medicines when sick. They also placed more value
on national brand OTC medicines than private brands (likely due to advertisements). This finding suggests
individuals with a low SES do not select OTC medicines based on their effects or ingredients. Regarding attitudes
toward OTC medicines, Japanese participants seemed to be unaware of the potential for abuse and side effects
associated with OTC medicines. Finally, in relation to caregivers’ self-medication practices for their children, the
majority of participants reported taking their children to the hospital since children tend to receive free medical
care. Furthermore, caregivers with a high educational background are more confident in being able to help
manage their children’s health.
Conclusions: Our results suggest that health and medical discrepancies among Japanese consumers pose new
social problems. In Japan, universal health care is available, but the cost of receiving medical care is not completely
free of charge. Thus, we hope that the government will attempt to meet the various needs of patients and support
their well-being. Consumers also have to be more independent and aware of their health management, as
self-medication practices will continue to play a more significant role in healthcare. More research is needed to find
ways to teach Japanese consumers/patients of both the benefits and risks of over-the-counter (OTC) medicines.
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Self-medication, which is a common self-care practice,
is widespread around the world [1]. Self-medication
products account for approximately 20% of the total
international pharmaceutical market [2]. Among various
self-medication options, the use of over-the-counter
(OTC) medicines is the most prevalent. In the U.K., an
estimated £1,268.5 million was spent on OTC medicines
in 1994, which equates to one-third of the total cost of
prescribed drugs [3]. In Germany, self-medication sales
were over £5.4 billion in 2006 [4]. The benefits of OTC
medicines include convenience to consumers/patients,
better self-management of minor problems, and a reduc-
tion in governmental medical costs. Thus, throughout
the world, a wider range of medicines is becoming avail-
able directly to the public [2], and the current practice
of self-medication offers consumers/patients more flex-
ible choices in health management.
Self-care choices vary according to sex, age, and socio-
economic status (SES). For example, in Ireland, females
report buying OTC medicines more often than do males,
and younger adults report buying OTC medicines more
often than older adults do [5]. With regard to SES, costs
can function as a barrier that reduces access to prescrip-
tion medicines [6], but the significance of this variable
depends on the healthcare system within a particular
country. In the U.S., where a universal health care sys-
tem is unavailable, a study found that a significantly
large number of mothers without health insurance were
likely to give OTC medicines to their young children [7].
In contrast, in Denmark, a country with an established
universal health care system, medical costs do not ap-
pear to function as a barrier that reduces access to pre-
scription medicines [6]. In Japan, the effects of a long-
term recession have negatively influenced the overall
economic situation of many individuals. Thus, a med-
ical/health discrepancy between people low and high in
SES is apparent. Do people at lower SES levels hesitate
to see a doctor because of medical costs? This question
has yet to be well researched. When people at lower SES
levels are encouraged to practice self-medication, are
they able to choose medicines based on valid evidence of
the medicine’s safety? Advertisements for OTC medi-
cines are legal in many countries, including Japan, and
such marketing might affect perceptions among consu-
mers/patients as to the benefits of different products [2].
Traditionally, patients are rather passive and dependent,
and they tend to follow the instructions of experts [1].
However, taking individual responsibility for safe self-
medication practices is increasingly necessary as several
OTC medicines become available on the market.
When discussing self-medication issues, the topic of
self-medication for children is noteworthy. Research on
this topic has been accumulating within Westerncountries for over a decade. In the U.S., 70% of illnesses
among preschoolers were treated with non-prescription
medicines [7]. However, the use of non-prescription
medicines for children was often inappropriate. A U.S.
study found that 71% of caregivers have inappropriately
used non-prescription medicines for their children, and
10.9% reported that they only “sometimes” read labels
and drug information [8]. Similarly, parents in the U.K.
were generally unaware of potential side effects of OTC
medicines because they believe that “over-the-counter
medicines are not strong and were unlikely to harm
their child,” or they believe that “prescription medicines
are strong and otherwise carry risks” [9 p. 27]. On the
other hand, Du and Knopf [4] conducted a profile ana-
lysis of caregivers who use OTC medicines and found
“the higher the socioeconomic status of the children’s
family, or the higher the educational level of the chil-
dren’s mother, the more OTC medicines the children
were likely to receive” (p. 606). Because OTC medicines
for children are relatively new in Japan, few studies have
been conducted. Therefore, it is necessary for public
health policy makers to explore how self-medication is
practiced for children in order to better construct paren-
tal education regarding OTC administration. Caregivers’
demographic information, along with their attitudes,
must be addressed.
In Japan, the revised Pharmaceutical Affairs Act was
only recently enacted in 2009; this introduced the con-
cept of self-medication. In 2008, a group of Japanese
researchers asked approximately 1,000 adults if they
knew the term “self-medication” and 60.5% did not
recognize this term [10]. However, research on self-
medication issues is important given the fact that declin-
ing birthrates and a growing proportion of elderly people
will have a significant impact on the Japanese pension
and social welfare system in the near future.
Therefore, the goals of the present study were to
examine the following: (1) how Japanese consumers/
patients practice self-medication to manage their health
problems, (2) how Japanese consumers/patients select
particular OTC medicines, (3) how consumers/patients’
attitudes toward OTC medicines, and (4) caregiver-
initiated medication behaviors for children. This study
also investigated the role of sex, age, and socioeconomic
status (SES) on the preceding research questions.
Method
Participants
Participants were 403 adults living in the Kanto area of
Japan, which consists of seven prefectures including
Tokyo (Mage = 41.12, SD = 16.19, range 20–79, male =
47.4%, female = 52.6%). The research company, Media
Interactive Inc., recruited participants in 2011. Among
the 403 participants, 331 had children.
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the following three age groups: a young group (20–29),
middle age group (30–49) and a senior group (65 years
old and above). There were an approximately equal
number of male and female participants within each
stratum (Table 1). These three age groups were selected
for the following reasons. First, we wanted to examine
how parents of young children (elementary school and
younger) practiced self-medication for both their chil-
dren and themselves. Thus, we placed a focus on asses-
sing participants in their 30s and 40s. Second, we
wanted to examine age differences in self-medication
practices. These age groups (20s, 30 − 40s, and 65 and
older) are especially important groups to address given
the intergenerational economic inequality in Japan.
According to a report from the Cabinet Office, Govern-
ment of Japan (2012), the differences in net benefit (the
ratio of net benefit from the social security system rela-
tive to lifetime income) between younger and older
adults is 12% [11]. The government is acutely aware of
the fact that the younger generation suffers a larger net
burden and believes that intergenerational inequality
should not be ignored.Procedures
All of the survey questions were uploaded online. The
participants who agreed to complete the survey accessed
it through a provided URL. After filling out the online
survey, Media Interactive Inc. gave the participants
points that could be accumulated in exchange for a gift
card.Questionnaire and measures
Participants answered 43 questions, including informa-
tion about demographics. The survey inquired about
self-medication behaviors (for the individual and for
children if the participant was a parent) and the reasons
for their choice, the choice of OTC medicines, and atti-
tudes toward OTC medicines (for the individual and for
children if the participant was a parent).Table 1 Participants’ sex and age
n %
Total (N) 403 100.0
Male: 20s 61 15.1
Male: 30–40s 90 22.3
Male: 65–79 40 9.9
Female: 20s 82 20.3
Female: 30–40s 90 22.3
Female: 65–79 40 9.9
Note: There were no participants in the 50–64-year-old category.Self-medication behaviors
Self-medication behaviors were measured by the ques-
tion: “When you have a high fever (39°C/102.2°F or
higher), what do you do?” Response choices were (1) I
will see a doctor and treat with prescribed drugs, (2) I
will treat with OTC medicines, (3) I will rest for a while,
(4) I will treat with an alternative method such as acu-
puncture and reflexology, or (5) Other. Next, partici-
pants were asked the reason for their choice (e.g., “Why
do you see a doctor?” or “Why don’t you see a doctor?”).
For their children, the question was, “When your child
has a high fever (39°C/102.2°F or higher), what do you
do?”
The choice of OTC medicines
The choice of OTC medicines was measured by the
question: “Which OTC medicines do you want to buy
when you treat your illness?” Response choices were: (A)
a national brand OTC medicine often seen in a TV ad-
vertisement or (B) a private brand OTC medicine that
has the same effects and ingredients but is 50% cheaper
than the national brand. National brand OTC medicines
refer to medicines produced by a major pharmaceutical
company (i.e., Tylenol and Advil in the U.S.). On the
other hand, private brand OTC medicines refer to medi-
cines that are similar to a national brand OTC medicine
but are sold at specific retailers (i.e., Walmart). Examples
of OTC medicines in Japan are aspirin and cough and
cold medicines; antibiotics are not included.
In terms of reasons for selecting a national brand
OTC medicine, response choices were (1) I feel safe be-
cause I often see the item on a TV advertisement, (2) I
feel safe because a well-known pharmaceutical company
produces it, (3) I feel safe because I have always taken
the same medicine, (4) Cheap medicines make me feel
anxious, (5) Unknown pharmaceutical companies make
me feel anxious, (6) More expensive medicines seem to
work better, (7) I like the package design, or (8) Other.
Response choices for selecting a private brand OTC
medicine were (1) It is cheaper, (2) Ingredients and ef-
fectiveness will be the same as the national brand OTC
medicine, (3) There will not be a big difference among
OTC medicines, (4) It seems better than the national
brand sold by a major pharmaceutical company, (5) I
like the package design, or (6) Other.
Attitudes toward OTC medicines
Several questionnaires developed by Bradley et al., [3]
Trajanovska, Manias, Cranswick, and Johnston [12], and
Wazaify et al. [5] were adapted and translated for this
study to measure patients’ attitude toward medicines.
The questionnaire consisted of 23 questions measuring
positive and negative attitudes toward OTC medicines,
perceived value and side effects of OTC medicines, and
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items and responses are listed in Table 2.
Caregiver-initiated medication behavior for children
Six questions from Maiman, Becker, Cummings, Drachman,
and O’Connor [13] were used and translated to assess
caregiver-initiated medication behavior for children.
The questionnaire evaluated caregivers’ beliefs about
their efficacy in managing the health of their children
and their attitudes toward OTC medicines. All ques-
tionnaire items and responses are listed in Table 3.
Socioeconomic status (SES)
SES was measured by annual income in Japanese yen.
Possible responses were (1) less than 300 K, (2) 301–
400 K, (3) 401–500 K, (4) 501–600 K, (5) 601–800 K, (6)
801–1000 K, (7) 1001–1500 K, or (8) 1501 K and above.
Data analysis
Various chi-square (χ2) analyses were conducted to exam-
ine the presence of any differences in self-medicationTable 2 Patients’ attitude toward OTC medicines: questions a
The chemist is a good source of advice/information about minor medical pro
A person should take medicines/treatment only when it is necessary.
You get good value from a doctor’s prescription.
Even if I have a health problem, I prefer to avoid taking any medicines.
We should be careful with non-prescribed OTC medicines.
People are less likely to bother their doctor with minor problems nowadays.
Only medicines/treatment from a doctor will really help.
Medicines/treatments you can buy are just as effective as those you get from
Overall, seeing a doctor costs me less than buying OTC medicines.
Generally, I find the medicines you can buy are less effective.
More prescribed drugs should be deregulated to OTC status.
Prescription medicines are completely safe to use.
Non-prescription medicines can have dangerous side effects.
Non-prescription medicines can sometimes mask serious health problems.
Some non-prescription medicines interfere with the natural healing process
With continual use, some non-prescription medicines lose their effectiveness
Some non-prescription medicines may cause dependency or addiction if tak
period of time.
Reading the label on the package is one of the ways I decide which medicin
Advertisements help me to learn what types or brand of medicines you can
I sometimes cannot afford to buy all the medicines I would like to buy myse
(without a prescription).
I sometimes cannot afford to buy all the items on a prescription issued by a
If I am unsure about a problem, I always look for advice from a doctor or nu
I read the instructions carefully before taking a medicine or treatment for thebehaviors and the choice of OTC medicines according
to sex, age, and SES. Phi coefficients (Φ) were calculated
as measures of effect size. Phi values of 0.1, 0.3, and 0.5
may be interpreted as indicating a small, medium, and
large effect between groups, respectively [14]. Standar-
dized residuals within each cell greater or lesser than
1.96 were considered to be statistically significant at the
.05 level. Subsequently, ANOVAs were conducted to
examine which demographic variables were related to
attitudes toward OTC medicines. There were no missing
data, and SPSS 18.0 was used for all data analyses.
Results
Descriptive statistics
Participants’ demographic information is summarized in
Tables 1 and 4.
Regarding descriptive statistics for self-medication
practice, 65.8% of the participants chose, “(When I have
high fever) I will see a doctor and treat with prescribed
drugs.” When asked to explain their behavior, one-third





blems. 14.9 67.2 15.6 2.2
60.3 36.5 2.2 1.0
23.1 66.0 10.7 0.2
17.4 35.7 39.5 7.4
18.4 52.6 27.8 1.2
18.4 49.9 27.0 4.7
3.7 18.4 57.3 20.6
a doctor. 3.0 18.4 57.3 20.6
7.7 43.2 39.5 9.7
7.4 38.7 48.6 5.2
7.4 49.9 38.5 4.2
7.9 46.7 40.7 4.7
3.5 30.0 62.5 4.0
8.2 50.9 39.0 2.0
of the body. 4.0 38.5 55.1 2.5
. 11.4 53.1 33.7 1.7
en for a long 8.2 47.1 40.9 3.7
es to take. 29.3 58.6 10.7 1.5
buy. 3.7 39.7 47.6 8.9
lf 10.9 32.5 44.7 11.9
doctor. 4.0 16.9 58.6 20.6
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Family is very often troubled by sickness. 7.1 23.4 56.0 13.5
I usually trust my own opinions about my child’s health more than a doctor’s opinion. 3.5 11.3 63.1 22.0
You have to use your own judgment in deciding how much of a doctor’s advice to
follow.
11.3 61.7 24.1 2.8
I have been satisfied with prescription medicines I’ve given a child. 5.7 72.3 20.6 1.4
When I give a child an OTC medicine, I am as careful as I am when giving prescribed
medicines.
22.0 56.7 18.4 2.8
I sometimes give a child OTCs in addition to those prescribed by a doctor for a problem. 2.1 22.0 34.0 41.8
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ments.” The participants who chose, “I will treat the
problem with OTC medicines” comprised 18% of the
total group. When asked to explain their behavior, 20.3%
of this group reported, “I want to treat the problem by
myself,” and 19.6% reported, “First, I want to see if OTC
medicines work for me.” For a summary of responses,
see Tables 5, 6, 7.
However, when a child has a high fever, more than
90% of the caregivers would take their child to the doc-
tor. The most common response was “We are not health
care professionals; thus, we should not make our own
judgments (63%).” The second most common response
was “Medical costs are free for children” (12.6%).
With the regard to the question, “Which OTC medi-
cines do you want to buy when you treat your illness,”
51.4% chose (A) a national brand OTC medicine, and
48.6% chose (B) a private brand OTC medicine. Logistic
regression was performed in the selection of either a na-
tional brand or a private brand; however, none of the in-
dependent variables (age group, sex, and SES) showed
significant group differences. Among respondents who
chose a national brand, 13.5% reported “I feel safe be-
cause I often see the item on TV advertisements,” 27.0%
reported “I feel safe because a well-known pharmaceut-
ical company produces it,” 45.9% reported “I feel safe be-
cause I have always taken the same medicine,” and
13.5% reported “Unknown pharmaceutical companiesTable 4 Participants’ income level
n %
Total (N) 403 100.0
Less than 300 K 72 17.9
301–400 K 73 18.1
401–500 K 67 16.6
501–600 K 50 12.4
601–800 K 65 16.1
801–1000 K 45 11.2
1001–1500 K 25 6.2
1501 K and more 6 1.5make me feel anxious.” In contrast, when respondents
who chose private brands were asked to explain their
behaviors, about 50% reported “Ingredients and effect-
iveness will be the same as national brand OTC medi-
cines,” and the other 50% reported “It is cheaper.” The
comparison could not be made for children because only
a few caregivers reported that they would use OTC med-
icines to treat their children’s high fever.Sex differences
A 2 (sex) × 5 (self-medication behavior choices) chi-
square analysis did not reveal statistically significant dif-
ferences, χ2 (3) = 2.18, p = 0.53, n.s. As for the choice of
OTC medicines, no sex difference was found. The
results suggest that participants’ self-medication beha-
viors and their choice of OTC medicines are not affected
by their sex. This is partially consistent with findings
reported by Hanibuchi [15], where no sex differences
emerged in whether or not participants saw a doctor.Age differences
A 3 (age group) × 5 (self-medication behavior choices)
chi-square analysis did not reveal statistically significant
differences, χ2 (6) = 11.06, p = 0.08, n.s. A 3 (age group) ×
2 (the choice of OTC medicines) chi-square analysis
also did not reveal statistically significant differences, χ2
(2) = 0.88, p = 0.64, n.s. The results suggest that age
group does not affect participants’ self-medication beha-
viors and choice of OTC medicines.Table 5 Summary of patients’ responses regarding
self-medication behaviors
n %
Total (N) 403 100.0
1 I will see a doctor and treat with prescribed drugs. 265 65.8
2 I will treat with OTC medicines. 72 17.9
3 I will rest and see for a while. 63 15.6
4 I will treat with alternative methods such as
acupuncture and reflexology.
3 0.7
5 Other 0 0.0
Table 6 Summary of patients’ responses regarding why
they see a doctor
n %
Total (N) 265 100.0
1 We use health care professionals; thus, we should
not make our own judgments.
168 63.4
2 I trust a doctor. 43 16.2
3 Seeing a doctor is free of charge for me. 3 1.1
4 Prescribed drugs are cheaper than OTC medicines. 15 5.7
5 I feel comfortable seeing the same doctor. 31 11.7
6 Other 5 1.9
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ing a doctor) chi-square analysis revealed statistically
significant age differences, χ2 (20) = 49.80, p < 0.01,
Φ = .60. The phi coefficient indicated a moderate effect
size. In examining the standardized residuals for each cell
within the chi-square analysis, a significantly larger number
of younger participants chose “(I am not going to see a
doctor because) it costs money” as compared to the other
two age groups. In addition, a significantly large number of
senior participants chose “(I am not going to see a doctor
because) there are no hospitals nearby” as compared to
the other two age groups. In sum, younger adults are less
likely to see a doctor because of financial constraints, and
transportation issues can mitigate older adults’ ability/
choice in seeing a doctor.
SES differences
A 6 (SES group) × 5 (self-medication behavior choices)
chi-square analysis did not reveal statistically significant
differences overall, χ2 (21) = 21.89, p = 0.40, n.s.
However, in examining the standardized residuals for
each cell within the chi-square analysis, results indicated
that a significantly larger number of people in the “lessTable 7 Summary of patients’ responses regarding why
they do not see a doctor
n %
Total (N) 138 100.0
1 I have no time to see a doctor. 9 6.5
2 It costs money. 19 13.8
3 First, I want to see if OTC medicines work for me. 27 19.6
4 If I rest, it will be okay. 24 17.4
5 I want to treat the problem by myself. 28 20.3
6 I don’t like doctors. 1 0.7
7 I don’t like hospitals. 5 3.6
8 There are no hospitals nearby. 1 0.7
9 There is no transportation to get to a hospital. 2 1.4
10 It bothers me to go to see a doctor. 18 13.0
11 Other 4 2.9than 300 K” group fell within the “will rest and see for a
while” category as compared to the rest of the SES
groups.
As for the choice of OTC medicines, a 6 (SES
groups) × 2 (the choice of OTC medicines) chi-square
analysis (χ2 (6) = 8.70, p = 0.19, n.s), a 6 (SES groups) × 5
(reason to pick private brand OTC medicines) chi-
square analysis (χ2 (12) = 6.51, p = 0.88, n.s.), and a 6
(SES groups) × 5 (reason to pick national brand OTC
medicines) chi-square analysis (χ2 (18) = 21.94, p = 0.23,
n.s) did not reveal statistically significant differences.
However, analyses of standardized residuals revealed that
participants in the group whose annual income was less
than 300 K were significantly more likely to fall into
the “I feel safe because I often see the item on TV”
and “Unknown pharmaceutical companies make me
feel anxious” categories than the rest of the SES groups.
In sum, people at lower SES levels are more likely to
be influenced by advertisements when selecting OTC
medicines. This is partially consistent with a U.S. study,
which found that caregivers with a lower annual
income (<US $20,000) are more likely to rely on pack-
aging than caregivers who have a higher annual income
(>US $ 60,000) [9].
Attitude toward OTC medicines
An analysis of participants’ awareness of side effects pro-
vided interesting results. Thirty percent of the partici-
pants agreed, and 3.5% strongly agreed, with the
statement “Non-prescription medicines can have danger-
ous side effects.” These are much lower percentages
compared with the findings of a European study in
which 59.7% of Irish respondents agreed and 5.9%
strongly agreed with that same statement [5]. Similarly,
only 38.5% of Japanese participants agreed with the
statement “Some non-prescription medicines interfere
with the natural healing process of the body,” as com-
pared to 50.5% of participants in Ireland. Regarding the
statement “Some non-prescription medicines may cause
dependency or addiction if taken for a long period of
time,” 47.1% of Japanese participants agreed compared
to 65.2% of Irish participants. These results indicate that
people in Ireland might be more aware of the potential
abuse of some OTC medicines [5] as compared to Japa-
nese participants.
Caregiver-initiated medication behavior for children
The majority of caregivers (78%) were satisfied with the
medicine they give to their children. Whereas 78.7% of
the caregivers answered, “When I give child an OTC
medicine, I am as careful as I am when giving prescribed
medicines,” 23.1% reported “I sometimes give a child
OTCs in addition to those prescribed by a doctor for a
problem”; thus, the results are somewhat contradictory.
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were also analyzed based on caregivers’ age, SES, and
educational level. Only education was a significant factor
in a chi-square analysis: χ2(15) = 27.43, p < 0.05. In exam-
ining the standardized residuals for each cell within the
chi-square analysis, caregivers who held a master’s de-
gree or above were more likely to answer “very true” for
“I usually trust my own opinions about my child’s health
more than a doctor’s opinion.” In other words, caregivers
with a higher educational background were more
confident in managing their children’s health.
Discussion
The goals of the present study were to examine the fol-
lowing: (1) how Japanese consumers/patients practice
self-medication to manage their health problems and the
reasons behind these practices, (2) how Japanese consu-
mers/patients select particular OTC medicines, (3) how
caregivers practice self-medication for their children,
and (4) caregivers’ attitudes toward self-medication for
their children. This study also investigated differences in
self-medication management and attitudes across sex,
age, and socioeconomic status (SES).
No significant sex differences were observed, but inter-
esting age differences emerged; younger adults were less
likely to see a doctor because of medical costs, and eld-
erly adults were less likely to see a doctor because they
lacked transportation. The younger-adult results partially
support previous research that found that about 50% of
younger adults (20s − 30s) were very anxious about their
future medical expenses [16].
With regard to SES, participants within lower income
levels were less likely to see a doctor or buy OTC medi-
cines for their health problems. This result is also con-
sistent with previous research showing that the number
of individuals who do not see a doctor when they are
sick because of costs more than doubles for individuals
in lower SES groups as compared to those in higher SES
groups [17]. However, Nielsen et al. [6] argue, “it is im-
portant that possible intervention by reimbursement sys-
tems is not socially imbalanced” [p. 199]. In Japan,
universal health care is available, but the cost of medical
attention is not completely free (as is the case in the
U.K.). For people who receive governmental financial
support in Japan, medical services dispensed at a hos-
pital are often free. However, there is no equivalent fi-
nancial support system helping those individuals
acquire OTC medicines for free or at a reduced cost.
Often, minor health problems can be treated with OTC
medicines, but if these opportunities are inaccessible,
medical attention might be postponed and problems
can get worse. Consequently, patients might end up
seeing a doctor and receiving long-term medical treat-
ment, which would be more costly for the governmentrelative to the cost of providing OTC medicines from
the beginning. Advocacy for active self-medication has
just begun during the past few years in Japan; thus,
usage patterns for OTC medicines in terms of a cost-
benefit analysis have yet to be assessed. Future research
should pursue this topic. We hope that the government
will attempt to meet the various needs of patients to
support their well-being.
When assessing reasons why participants chose either
national or private brand OTC medicines, results indi-
cated that people in the lower SES groups placed more
value on national brands than private brands. This was
because they often saw national brands advertised on
TV. These results suggest that OTC medicine advertise-
ments have a powerful affect on perceptions among low
SES consumers/patients. However, the influence of TV
advertisements on public perceptions of OTC medicines
has not been well researched. Advertisements on TV
convey both intentional and unintentional messages to
their audience, and consumers/patients should not rely
solely on information garnered from such advertise-
ments when choosing a product. Even though private
brand OTC medicines are cheaper and have the same
effects and ingredients as national brands, people among
low SES groups prefer national brands; this might be be-
cause unknown pharmaceutical companies evoke some
anxiety. In other words, low SES consumers might not
choose OTC medicines based on relevant criteria, such
as evidence of their effects or their ingredients. Even
though major pharmaceutical companies produce some
OTC medicines, consumers/patients still need to be
aware of their potential adverse effects and use them as
directed. Consumers/patients should consult a pharma-
cist to obtain more information, especially since phar-
macists are easier to access than are doctors. A study in
Ireland found that a recommendation by a pharmacist
most frequently influenced consumer/patients’ choice of
OTC medicines [5]. As self-medication practices become
more common, it is important to be a wise consumer to
improve one’s health and reduce medical costs. There-
fore, pharmacists might play a more active role to help
educate consumers/patients, especially since a large
number of people do not pay attention to written infor-
mation provided with medicines [18]. In fact, our
results showed that 67.2% of participants agree with the
statement “The chemist is a good source of advice/
information about minor medical problems,” with
14.9% strongly agreeing. Some consumers/patients may
not be ready to accept the more active role of pharma-
cists in their personal healthcare; however, pharmacists’
increasing involvement could lead to changes in public
attitudes [3].
Our study also observed that Japanese participants
were less aware of the potential for abuse and side
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to participants in a previous study conducted in Ireland
[5]. Since the Pharmaceutical Affairs Act was recently
revised and enacted in Japan, it is possible that Japanese
consumers/patients are not highly aware of the risks
associated with OTC medicines compared to Europeans.
In fact, Kawase et al. [19] found that Japanese consu-
mers/patients paid less attention to risk information la-
beled on OTC medicine packages than did Americans.
Finally, caregivers with higher educational back-
grounds are more confident in managing the health of
their children. As Du and Knopf [4] argue, “well-
educated mothers often believe they have enough med-
ical knowledge” [p. 607]. This trend is also consistent in
Japan. However, we did not observe significant differ-
ences in parents’ efficacy in dealing with their children’s
health based on SES. Given that medical costs for chil-
dren are free in Japan, access to health care professionals
is easy; thus, caregivers can take their children to the
hospital if necessary. In fact, the majority of our partici-
pants reported they would take their sick children to the
hospital instead of giving them OTC medicines. In
addition, the second most common reason for taking
their children to the hospital was “Free medical cost for
children.” This suggests that the social welfare system
for supporting children helps reduce caregivers’ anxiety.
Conclusions
Our results suggest that individuals within different age
groups and SES levels have different medical needs. This
is noteworthy because dramatic changes in the Japanese
social structure have occurred over the past few decades.
The number of senior citizens is rapidly increasing while
the birth rate remains low. In 2008, the birth rate was
1.37, a number that has not changed significantly over
the past 10 years [20]. Meanwhile, people tend to live
longer, and senior citizens now comprise 22.7% of the
total Japanese population according to recent govern-
mental statistics [21]. It is expected that senior citizens
will comprise 33.7% of the total Japanese population by
2035, and this figure will increase to 40.5% by 2055 [22].
As a result, the financial burden placed upon younger
adults will increase in order to support senior citizens in
Japan. Consequently, younger adults might forfeit the
opportunity to receive appropriate medical treatment
from a doctor. The existing governmental healthcare
system not match the current and future social struc-
ture. It is highly probable that more medical problems
and need for treatment will emerge within the changing
society; thus, we, as consumers/patients, have to change
our mindset. The governmental social welfare system
has functioned well, but it might not be as effective as it
is currently in the future. To accommodate the changing
social structure, people will need to become moreindependent in managing their health, and self-
medication practice will likely play a key role.
Our results also suggest that more research is needed
in order to find a way to teach both the benefits and
risks of OTC medicines to Japanese consumers/patients.
Along with public education, pharmaceutical companies
can also improve the methods they use to deliver med-
ical information. Raynor et al. [18] argue that risk infor-
mation delivered numerically, rather than verbal
descriptions, provides a more accurate estimation of the
probability and likelihood of understanding a side effect
or health risk. MacLennan & Sturdee [23] also suggest
that all medicines should have a simple, visible labeling
system on the outside of the package. Therefore,
pharmaceutical companies might want to connect better
with consumers/patients’ information processing sys-
tems by utilizing perspectives from cognitive psychology.
Finally, one limitation of this study is that it was cross-
sectional in nature, which makes it difficult to infer
causal relationships. Therefore, the generalizability of
our findings is limited, and future research is required.
Nevertheless, the present study brings a unique perspec-
tive to the literature by addressing differences in self-
medication practices and attitudes according to sex, age,
and SES among Japanese consumers/patients and
caregivers.
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